USPTO serial 88274762
PHARMASEAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 21, 2020
- Examiner
- MIRANDA, JOHN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PHARMASEAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,700
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
PharmaSEAL International Limited
Nottingham, GB
PharmaSEAL International Limited
Nottingham, GB
PharmaSEAL International Limited
Nottingham, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Molly B. Markley
Molly B. Markley YOUNG, BASILE, HANLON & MACFARLANE P.C.3001 WEST BIG BEAVER ROADSUITE 624TROY, MI 48084-3107Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for management of clinical trials; downloadable computer software for clinical and scientific research purposes; downloadable platform software for management of clinical trials; downloadable platform software for clinical and scientific research purposes; downloadable software applications in the nature of computer software for management of clinical trials; downloadable software applications for clinical and scientific research purposes; downloadable software for management of clinical trials; downloadable software for clinical and scientific research purposes; downloadable computer software for purposes related to clinical research and clinical trials; downloadable computer software for use in clinical research and clinical trials; downloadable computer software for use in the collection and management of clinical data; downloadable computer software for the collection, entry, analysis, management and validation of clinical research and clinical trial data; downloadable computer software for managing clinical trial data and information; downloadable computer software for use in the remote or local collection of clinical trial data; downloadable computer software for use in clinical trial design and development; downloadable computer software for use in clinical trial planning and management; downloadable computer software for use in clinical trial patient randomisation; downloadable computer software for use in clinical trial patient monitoring; downloadable computer software for use in clinical trial data management and analysis; electronic databases in the field of clinical and scientific research, recorded on computer media; electronic databases in the field of clinical trials, recorded on computer media; database management software; downloadable audio materials, audio-visual materials and video materials, namely, downloadable audio and video files relating to the pharmaceutical industries, drug development, clinical research, scientific research, clinical test, clinical trials and regulatory affairs; downloadable electronic publications in the nature of magazines about the pharmaceuticals industry, drug development, clinical research, scientific research, clinical test, clinical trials and regulatory affairs | ACTIVE | — |
| 041 | Educational services and training, namely, providing classes in the field of the pharmaceutical industries, drug development, clinical research, scientific research, clinical test, clinical trials and regulatory affairs; educational services, namely, classes in the field of the pharmaceutical industries; educational consulting services for pharmaceutical industries; training services for the pharmaceutical industries; educational services, namely, providing classes, training services and workshops in the field of the pharmaceutical industries, drug development, clinical research, scientific research, clinical test, clinical trials and regulatory affairs; educational services, namely, providing classes, training services and workshops in relation to pharmaceutical industries; educational services, namely, arranging and conducting workshops in the field of the pharmaceutical industries; educational services, namely, workshops for training purposes in the field of the pharmaceutical industries drug development, clinical research, scientific research, clinical test, clinical trials and regulatory affairs | ACTIVE | — |
| 042 | Software as a services (SaaS) featuring software for management of clinical trials; software as a services (SaaS) featuring software for clinical research and clinical trials; software as a services (SaaS) featuring software for management of clinical test and trials; software as a services (SaaS) featuring software for clinical testing; providing online non-downloadable software for clinical research and clinical trials; providing online non-downloadable software for clinical research and clinical trials; providing online non-downloadable software for management of clinical trials; providing online non-downloadable software for clinical testing; software customisation services; customisation of software for clinical research or clinical trials; customisation of software for management of clinical trials; customisation of software for clinical testing; design and development of computer software, computer programs and computer systems; design and development of computer software, computer programs and computer systems for clinical research and clinical trials; information, advisory and consultancy services in relation to the aforesaid services | ACTIVE | — |
| 045 | Consulting services in relation to regulatory compliance in the pharmaceutical industries; consulting services for the pharmaceutical industry in relation to the regulatory compliance of software; advisory and consultancy services, namely, regulatory compliance consulting services in the field of regulatory affairs and drug development; advisory and information services relating to all the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PharmaSEAL International Limited
- Other trademarks owned by PharmaSEAL International Limited
- Other trademarks owned by PharmaSEAL International Limited
- Other trademarks in Class 009
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named PHARMASEAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 21, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 21, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 5, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 5, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 15, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 1, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 19, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 19, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 19, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 7, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 7, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 7, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 17, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 17, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 16, 2019 | ALIE | ASSIGNED TO LIE | — |
| Sep 10, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 13, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 15, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 28, 2019 | NWAP | NEW APPLICATION ENTERED | — |